BridgeMD
New treatment option for Endometrioma
Official title Ethanol Sclerotherapy Prior to ART
ClinicalTrials.gov ID: NCT05962775
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to assess the impact of ethanol sclerotherapy on ART cycle outcomes. The main questions it aims to answer are: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only. Healthy volunteers may be eligible.
You may be able to join if
- AMH\>0.3 ng/ml
- unilateral/bilateral endometrioma
- Endometrioma diameter 40-100 mm
You likely can't join if
- 3 or more IVF/embryo transfer failure
- Menstrual cycle abnormalities
- Male Factor infertility
- Presence of uterine fibroids
- Presence of hydrosalpinx
- Presence of uterine abnormalities
See the full eligibility criteria
- AMH\>0.3 ng/ml
- unilateral/bilateral endometrioma
- Endometrioma diameter 40-100 mm
- 3 or more IVF/embryo transfer failure
- Menstrual cycle abnormalities
- Male Factor infertility
- Presence of uterine fibroids
- Presence of hydrosalpinx
- Presence of uterine abnormalities
- Suspicion of malignancy according to International Ovarian Tumor Analysis criteria
The study team makes the final eligibility decision.
Where it's taking place
- Adana, Turkey (Türkiye)
- Ankara, Turkey (Türkiye)
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Adana, Turkey (Türkiye); Ankara, Turkey (Türkiye); Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.